Immunometabolic rewiring in macrophages for periodontitis treatment via nanoquercetinmediated leverage of glycolysis and OXPHOS
文献类型:期刊论文
作者 | Zhang, Yi1,4; Shi, Junyu1; Zhu, Jie4; Ding, Xinxin1; Wei, Jianxu1; Jiang, Xue1; Yang, Yijie1; Zhang, Xiaomeng1; Huang, Yongzhuo2,3,4![]() |
刊名 | ACTA PHARMACEUTICA SINICA B
![]() |
出版日期 | 2024-11-01 |
卷号 | 14期号:11页码:5026-5036 |
关键词 | Quercetin Periodontitis Macrophage Glycolysis Oxidative phosphorylation (OXPHOS) Mesoporous polydopamine Mitochondrial reactive oxygen species Immunometabolic rewiring |
ISSN号 | 2211-3835 |
DOI | 10.1016/j.apsb.2024.07.008 |
通讯作者 | Zhang, Xiaomeng(119039@sh9hospital.org.cn) ; Huang, Yongzhuo(yzhuang@simm.ac.cn) ; Lai, Hongchang(laihongchang@sjtu.edu.cn) |
英文摘要 | Periodontitis is a chronic inflammatory disease marked by a dysregulated immune microenvironment, posing formidable challenges for effective treatment. The disease is characterized by an altered glucose metabolism in macrophages, specifically an increase in aerobic glycolysis, which is linked to heightened inflammatory responses. This suggests that targeting macrophage metabolism could offer a new therapeutic avenue. In this study, we developed an immunometabolic intervention using quercetin (Q) encapsulated in bioadhesive mesoporous polydopamine (Q@MPDA) to treat periodontitis. Our results demonstrated that Q@MPDA could reprogram inflammatory macrophages to an antiinflammatory phenotype ( i.e. , from-M1-to-M2 repolarization). In a murine periodontitis model, locally administered Q@MPDA reduced the presence of inflammatory macrophages, and decreased the levels of inflammatory cytokines (IL-1b and TNF-a) and reactive oxygen species (ROS) in the periodontium. Consequently, it alleviated periodontitis symptoms, reduced alveolar bone loss, and promoted tissue repair. Furthermore, our study revealed that Q@MPDA could inhibit the glycolysis of inflammatory macrophages while enhancing oxidative phosphorylation (OXPHOS), facilitating the shift from M1 to M2 macrophage subtype. Our findings suggest that Q@MPDA is a promising treatment for periodontitis via immunometabolic rewiring. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
WOS关键词 | OXIDATIVE STRESS ; CROSSTALK ; TUMOR |
资助项目 | National Key Research and Development Program of China, China[2022YFE0203600] ; National Nature Science Foundation of China[82271028] ; Department of Science and Technology of Guangdong Province (High-level New R&D Institute, China)[2019B090904008] ; Department of Science and Technology of Guangdong Province (High-level Innovative Research Institute, China)[2021B0909050003] ; Zhongshan Municipal Bureau of Science and Technology, China[LJ2021001] ; Zhongshan Municipal Bureau of Science and Technology, China[CXTD2022011] ; Project of Biobank, China[YBKB202102] ; Research Discipline Fund, China[KQYJXK2020] ; Cross-disciplinary Research Fund, China[JYJC202205] ; Shanghai Ninth People's Hospital, China[SHSMU-ZDCX20212500] ; Shanghai Pujiang Program, China[22PJD038] ; [82341232] |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:001363518700001 |
出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
源URL | [http://119.78.100.183/handle/2S10ELR8/314686] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Zhang, Xiaomeng; Huang, Yongzhuo; Lai, Hongchang |
作者单位 | 1.Shanghai Jiao Tong Univ, Natl Clin Res Ctr Oral Dis, Shanghai Key Lab Stomatol,Shanghai Peoples Hosp 9, Dept Implant Dent,Coll Stomatol,Sch Med, Shanghai 200011, Peoples R China 2.NMPA Key Lab Qual Res & Evaluat Pharmaceut Excipie, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528437, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Yi,Shi, Junyu,Zhu, Jie,et al. Immunometabolic rewiring in macrophages for periodontitis treatment via nanoquercetinmediated leverage of glycolysis and OXPHOS[J]. ACTA PHARMACEUTICA SINICA B,2024,14(11):5026-5036. |
APA | Zhang, Yi.,Shi, Junyu.,Zhu, Jie.,Ding, Xinxin.,Wei, Jianxu.,...&Lai, Hongchang.(2024).Immunometabolic rewiring in macrophages for periodontitis treatment via nanoquercetinmediated leverage of glycolysis and OXPHOS.ACTA PHARMACEUTICA SINICA B,14(11),5026-5036. |
MLA | Zhang, Yi,et al."Immunometabolic rewiring in macrophages for periodontitis treatment via nanoquercetinmediated leverage of glycolysis and OXPHOS".ACTA PHARMACEUTICA SINICA B 14.11(2024):5026-5036. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。